PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 162 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $50,000 | -23.1% | 7,106 | 0.0% | 0.00% | – |
| Q2 2021 | $65,000 | -5.8% | 7,106 | 0.0% | 0.00% | – |
| Q1 2021 | $69,000 | -5.5% | 7,106 | 0.0% | 0.00% | – |
| Q4 2020 | $73,000 | +1.4% | 7,106 | 0.0% | 0.00% | – |
| Q3 2020 | $72,000 | -2.7% | 7,106 | 0.0% | 0.00% | – |
| Q2 2020 | $74,000 | +23.3% | 7,106 | 0.0% | 0.00% | – |
| Q1 2020 | $60,000 | +13.2% | 7,106 | +16.8% | 0.00% | – |
| Q4 2019 | $53,000 | -19.7% | 6,086 | 0.0% | 0.00% | – |
| Q3 2019 | $66,000 | -14.3% | 6,086 | 0.0% | 0.00% | – |
| Q2 2019 | $77,000 | -67.4% | 6,086 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $236,000 | +90.3% | 6,086 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $124,000 | -55.6% | 6,086 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $279,000 | -22.5% | 6,086 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $360,000 | -13.0% | 6,086 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $414,000 | -35.3% | 6,086 | -5.9% | 0.00% | -25.0% |
| Q4 2017 | $640,000 | -17.4% | 6,471 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $775,000 | +36.9% | 6,471 | 0.0% | 0.01% | +50.0% |
| Q2 2017 | $566,000 | +134.9% | 6,471 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $241,000 | +21.1% | 6,471 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $199,000 | -54.1% | 6,471 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $434,000 | +124.9% | 6,471 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $193,000 | -9.8% | 6,471 | -11.0% | 0.00% | 0.0% |
| Q1 2016 | $214,000 | -62.5% | 7,274 | -0.0% | 0.00% | -60.0% |
| Q4 2015 | $570,000 | +4.0% | 7,275 | +0.1% | 0.01% | 0.0% |
| Q3 2015 | $548,000 | -35.5% | 7,268 | -0.1% | 0.01% | -28.6% |
| Q2 2015 | $850,000 | -44.4% | 7,277 | +12.5% | 0.01% | -46.2% |
| Q1 2015 | $1,528,000 | +24.7% | 6,471 | 0.0% | 0.01% | +30.0% |
| Q4 2014 | $1,225,000 | -20.7% | 6,471 | 0.0% | 0.01% | -23.1% |
| Q3 2014 | $1,544,000 | +119.6% | 6,471 | -39.2% | 0.01% | +116.7% |
| Q2 2014 | $703,000 | – | 10,651 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |